The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 St Jude Medical Inc  (STJ) Trade Now »     Rate STJ  -  Discuss STJ  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Medical Equipment & Supplies
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
95.0%
Top:
100.0%
Rate STJ:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

STJ: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Bullish on STJ ... Graphic_rating_buy STJ
Foto
62%
 -13.27%
in 502 days
Analysts' Recommendation: Buy 30 Days Ago: Buy Analysts' Target: $51 Analysts' Targets Leerink Swann & Company $51 Outperform Monday, June 23, 2008 Lazard Capital Markets $52 Strong Buy Thursday, April 17, 2008 Rodman & Renshaw Inc. $50 Mkt Outperform Thursday, February 28, 2008 Deutsche Bank Securities $48 Accumulate Thursday, January 24, 2008 UBS Securities $45 Add Thursday, January 24, 2008 Stanford Group Company $50 Buy Thursday, January 24, 2008 Friedman, Billings, Ramsey & C $61 ...
By  Marian Filo   (-24.55%  risk: aggressive)  07/12/08 Comment


Technicals are favorable Graphic_rating_buy STJ
Dscf0003
14%
 +0.00%
in 40 minutes
(closed on 01/29/08)
Short, medium term technical indicators point to revival in trend and market sentiment toward this stock is improving.
By  puritan   (-10.32%  risk: moderate)  01/29/08 Comment


STJ is a BUY Graphic_rating_buy STJ
 4 %
 -16.48%
in 894 days

Traders at Palma are Bullish on STJ

www.palmaresearch.com/default.aspx?viewreport=STJ

 

By  traderthoughts   (-10.26%  risk: aggressive)  06/16/07 Comment








From the Blogosphere

Boston Scientific’s New Product – Analyst Blog
Logo1
38%

Boston Scientific Corp. (BSX) recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex Fully Covered Esophageal Stent in the U.S. and Europe. The new product is used for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
 
With the new approval, Boston’s complete portfolio of WallFlex Stent family of self-expanding metal stents is now available in the U.S. , Europe and other international markets. The company had earlier receive< />< />< />< />< />< /><><><><><><><><>< /><>< /><>< /><>< /><>< /><>< /><>< /><><>< /><>< /><>< />< />...
By  StraightStocks   (-6.57%  risk: moderate)  11/25/09 Comment


Medtronic Beats Zacks Estimate – Analyst Blog
Logo1
38%

Medtronic, Inc. (MDT) reported second-quarter of fiscal 2010 earnings per share of 77 cents, compared to the Zacks Consensus Estimate of 74 cents and the year-ago earnings per share of 67 cents.

<u>Sales</u>
Total revenues in the reported quarter increased 8% year over year to $3.838 billion. Growth was witnessed across all the seven business segments. Cardiac Rhythm Disease Management (CRDM) revenues increased 3% year over year to $1.278 billion, driven by strong demand for the company’s implantable cardioverter defibrillators (ICDs). Spinal revenues increased 4% year over year to $862 milli< />< />< />< />< />< />< />< />< />< />< />< />< />< />< />< />< />< />< /><><><><>< /><>< /><>< /><>< /><>< /><><>< /><>< /><>< />< />...
By  StraightStocks   (-6.57%  risk: moderate)  11/25/09 Comment


Zacks #5 Rank Additions for Wednesday – Zacks Tale of the Tape
Logo1
38%

Here are the stocks added to the Zacks #5 Rank ("strong sell") List today:

  • First Security Group Inc (FSGI)
  • Iconix Brand Group Inc (ICON)
  • Mosaic Co (MOS)
  • National Retail Properties Inc (NNN)
  • Navigators Group Inc (NAVG)
  • Prudential PLC (PUK)
  • Psychiatric Solutions Inc (PSYS)
  • St Jude Medical Inc (STJ)

View the entire Zacks #5 Rank List
"FSGI" Free Stock Analysis: Buy? Sell? Hold?
"ICON" Free Stock Analysis: Buy? Sell? Hold?
"MOS" Free Stock Analysis: Buy? Sell? Hold?
"NNN" Free Stock Analysis: Buy? Sell? Hold?
"NAVG" Free Stock Analysis: Buy? Sell? Hold?
<>"PUK" Free Stoc...
By  StraightStocks   (-6.57%  risk: moderate)  11/25/09 Comment


St. Jude Medical: Filling-the-Gap on Short Squeeze

St. Jude Medical (STJ) took a nasty beating last month as their earnings outlook and several analyst downgrades. Yesterday we saw the first upgrade – all the way to a buy. This is creating a short-squeeze as it passes above resistance and creates a fill-the-gap scenario.

October downgrades:
By  trackseekingalpha   (-11.17%  risk: aggressive)  11/25/09 Comment


St. Jude Medical (STJ) – Filling-the-Gap on Short Squeeze
St. Jude Medical (STJ) took a nasty beating last month as their earnings outlook and several analyst downgrades. Today we are seeing the first upgrade – all the way to a buy. This is creating a short-squeeze as it passes above resistance and creates a fill-the-gap scenario. October downgrades: Oct 22, 2009 10:11 AM FTN Equity [...] Related posts:
  1. Potash (POT) Seeing Unrelenting Price Squeeze
  2. T. Rowe Price – How Low Does it Go?
  3. Why We are Short Exxon
By  Andrew Horowitz   (-9.98%  risk: moderate)  11/24/09 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 381
2 Gerald Greene 18.14 +72.34% 210
3 stockmarketfunding.com 17.66 +25.65% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment
BIDU Baiducom Inc ADS
RIO Companhia Vale Do Rio Doce
GLD streetTRACKS Gold
IBM International Business Machines Corp
DELL Dell Inc
LEH Lehman Brothers Holdings Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on STJ

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About St Jude Medical Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch